关节设备市场规模、份额、成长分析（按产品、应用、最终用户和地区）- 2025 年至 2032 年产业预测

预计 2023 年全球关节装置市场价值将达到 29.4 亿美元，从 2024 年的 30.9 亿美元增长至 2032 年的 46 亿美元，预测期内（2025-2032 年）复合年增长率为 5.1%。

受心血管、神经血管和周边血管疾病发病率上升的推动，全球封堵装置市场呈现强劲成长动能。闭塞解除、栓塞和支持装置等关键产品对于有效的治疗通讯协定至关重要。人口老化和微创手术技术的进步进一步推动了市场扩张。此外，血管内手术的转变以及对门诊手术中心等门诊病人环境的偏好日益增加也在推动需求。由于心血管疾病的高发性和主要製造商的存在，北美占据市场领先地位。另一方面，由于医疗保健基础设施的改善和患者意识的提高，欧洲和亚太地区正在经历显着的成长。预计这一趋势在不久的将来还将继续下去。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

关节装置市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 堵塞清除装置
  • 气囊连接装置
  • 支架回收装置
  • 线圈回收器
  • 吸痰器及吸痰装置
• 栓塞装置
  • 栓塞线圈
  • 液态栓塞剂
  • 肾小管封堵器
• 支援的设备
  • 微导管
  • 导管导引线

关节装置市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 神经病学
• 心臟病学
• 周围血管疾病
• 泌尿系统
• 肿瘤学
• 妇科

关节设备市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊断中心
• 手术中心
• 门诊治疗中心
• 研究实验室和学术机构

关节装置市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Boston Scientific Corporation（United States）
• Medtronic PLC（Ireland）
• Terumo Corporation（Japan）
• Stryker Corporation（United States）
• Penumbra, Inc.（United States）
• Abbott Laboratories（United States）
• Edwards Lifesciences Corporation（United States）
• Johnson & Johnson（United States）
• Merit Medical Systems, Inc.（United States）
• Lepu Medical Technology Co., Ltd.（China）
• Asahi Intecc Co., Ltd.（Japan）
• AngioDynamics, Inc.（United States）
• Cardinal Health, Inc.（United States）
• Avinger, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• CR Bard, Inc.（United States）
• Cook Medical Incorporated（United States）
• Acrostak International Distribution Sarl（Switzerland）

结论和建议

Global Occlusion Devices Market size was valued at USD 2.94 billion in 2023 and is poised to grow from USD 3.09 billion in 2024 to USD 4.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global occlusion devices market is on a robust growth trajectory, driven by the rising incidence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Key products including occlusion removal devices, embolization devices, and support devices are integral to effective treatment protocols. The aging population and advancements in minimally invasive surgical techniques are further propelling market expansion. Moreover, the shift towards endovascular procedures and an increasing preference for outpatient settings, like ambulatory surgical centers, are boosting demand. North America leads the market, thanks to a high prevalence of cardiovascular issues and the presence of major manufacturers. Meanwhile, Europe and Asia-Pacific are experiencing significant growth due to enhanced healthcare infrastructure and rising patient awareness. This trend is expected to persist in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segmental Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The global occlusion devices market is primarily driven by the rising prevalence of cardiovascular and neurovascular diseases, as well as peripheral vascular conditions. The growing incidence of these health issues necessitates effective therapeutic solutions like occlusion devices to restore blood flow and mitigate complications. This demand is further amplified by an aging population and increasing unhealthy lifestyle choices. Additionally, advancements in minimally invasive techniques have transformed occlusion treatment, offering patients non-surgical options that reduce trauma, expedite recovery, and enhance outcomes. The introduction of innovative devices, including occlusion removal and embolization devices, with improved safety and efficacy, is fostering significant market growth.

Restraints in the Global Occlusion Devices Market

The global occlusion devices market faces several significant restraints, primarily due to rigorous regulatory approval processes designed to ensure patient safety and product effectiveness. Securing necessary approvals, such as those from the FDA or obtaining CE marking, is often a lengthy and expensive endeavor. This regulatory landscape presents considerable hurdles, especially for small and medium-sized enterprises looking to enter or enhance their market footprint. Additionally, the high costs associated with manufacturing occlusion devices-encompassing occlusion removal, embolization, and support devices-are another limiting factor. The substantial expenses tied to research, development, and the use of specialized materials drive up prices, restricting market access and adoption, particularly in regions with constrained healthcare budgets and emerging economies where affordability is a critical concern.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a significant shift towards bioresorbable occlusion devices, driven by their ability to dissolve and be absorbed by the body, thereby eliminating the need for device removal procedures. This burgeoning demand is largely fueled by the advantages these devices offer, including minimized long-term complications and enhanced patient comfort. Manufacturers are increasingly channeling investments into research and development to refine bioresorbable materials, focusing on boosting safety and efficacy. This trend reflects a broader movement toward patient-centric healthcare solutions, highlighting a growing preference for personalized treatment options within the realm of occlusion device interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Occlusion Removal Devices
  • Balloon Occlusion Devices
  • Stent Retrievers
  • Coil Retrievers
  • Suction & Aspiration Devices
• Embolization Devices
  • Embolic Coils
  • Liquid Embolic Agents
  • Tubal Occlusion Devices
• Support Devices
  • Microcatheters
  • Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neurology
• Cardiology
• Peripheral Vascular Diseases
• Urology
• Oncology
• Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers,
• Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acrostak International Distribution Sarl (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations